Jun‐ya Kato
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Cell Biology top 0.2%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 35
- Epigenetics and DNA Methylation 12
- RNA modifications and cancer 7
- Oncology 60
- Cancer-related Molecular Pathways 48
- Co-authors
- Charles J. Sherr (19 shared papers)Mark E. Ewen (3 shared papers)C J Sherr (3 shared papers)Martine F. Roussel (11 shared papers)H Matsushime (2 shared papers)Joan Massagué (2 shared papers)Kornélia Polyák (2 shared papers)Dawn E. Quelle (4 shared papers)
- Journals
- Molecular and Cellular Biology (17 papers)Journal of Biological Chemistry (7 papers)FEBS Letters (6 papers)Blood (4 papers)Advanced Pharmaceutical Bulletin (4 papers)
- Partner nations
- JapanUnited StatesIndonesia
In The Last Decade
Jun‐ya Kato
111 papers receiving 13.6k citations
Jun‐ya Kato's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 7.6k
- Cell Biology 2.5k
- Molecular Biology 9.6k
- Cancer Research 1.3k
- Biotechnology 699
Countries citing papers authored by Jun‐ya Kato
This map shows the geographic impact of Jun‐ya Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐ya Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐ya Kato more than expected).
Fields of papers citing papers by Jun‐ya Kato
This network shows the impact of papers produced by Jun‐ya Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐ya Kato. The network helps show where Jun‐ya Kato may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐ya Kato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Hit paper breakdown → | 1994 | 1677 |
| 2 | Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 Hit paper breakdown → | 1993 | 1070 |
| 3 | D-type cyclin-dependent kinase activity in mammalian cells. Hit paper breakdown → | 1994 | 965 |
| 4 | Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Hit paper breakdown → | 1993 | 946 |
| 5 | Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Hit paper breakdown → | 1993 | 893 |
| 6 | Eight Calves Cloned from Somatic Cells of a Single Adult Hit paper breakdown → | 1998 | 821 |
| 7 | Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins Hit paper breakdown → | 1992 | 797 |
| 8 | Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation Hit paper breakdown → | 1994 | 664 |
| 9 | Inhibition of Cyclin‐Dependent Kinases by Purine Analogues Hit paper breakdown → | 1994 | 561 |
| 10 | Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 Hit paper breakdown → | 1999 | 545 |
| 11 | Novel INK4 Proteins, p19 and p18, Are Specific Inhibitors of the Cyclin D-Dependent Kinases CDK4 and CDK6 Hit paper breakdown → | 1995 | 534 |
| 12 | The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. Hit paper breakdown → | 1996 | 520 |
| 13 | 1994 | 304 | |
| 14 | 1994 | 259 | |
| 15 | 2002 | 244 | |
| 16 | 1993 | 212 | |
| 17 | 1994 | 177 | |
| 18 | 2018 | 171 | |
| 19 | 1986 | 153 | |
| 20 | 2004 | 133 |
About Jun‐ya Kato
Jun‐ya Kato is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Pharmacology, having authored 112 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (48 papers), Ubiquitin and proteasome pathways (35 papers), Microtubule and mitosis dynamics (14 papers), Epigenetics and DNA Methylation (12 papers), Biological Stains and Phytochemicals (10 papers), Curcumin's Biomedical Applications (10 papers), Cancer Research and Treatments (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Oncology (7.6k citations), Cell Biology (2.5k citations), Molecular Biology (9.6k citations), Cancer Research (1.3k citations) and Biotechnology (699 citations). Jun‐ya Kato has collaborated with scholars based in Japan, United States and Indonesia. Frequent co-authors include Charles J. Sherr, Mark E. Ewen, C J Sherr, Martine F. Roussel, H Matsushime, Joan Massagué, Kornélia Polyák, Dawn E. Quelle, Sheila Shurtleff and Hitoshi Matsushime. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, FEBS Letters, Blood and Advanced Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.